A Urinary Bcl-2 Surface Acoustic Wave Biosensor for Early Ovarian Cancer Detection


Onen O., Sisman A., Gallant N. D., Kruk P., Guldiken R.

SENSORS, vol.12, no.6, pp.7423-7437, 2012 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 6
  • Publication Date: 2012
  • Doi Number: 10.3390/s120607423
  • Journal Name: SENSORS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.7423-7437
  • Keywords: ovarian cancer, MEMS, piezoelectric, sensor, early detection, Bcl-2, SH, SAW, SAM, ultrasound, ESCHERICHIA-COLI, PROPAGATION, BIOMARKERS, DISCOVERY, EFFICACY, SENSORS, BIOLOGY, LINBO3, WOMEN, STAGE
  • Marmara University Affiliated: Yes

Abstract

In this study, the design, fabrication, surface functionalization and experimental characterization of an ultrasonic MEMS biosensor for urinary anti-apoptotic protein B-cell lymphoma 2 (Bcl-2) detection with sub ng/mL sensitivity is presented. It was previously shown that urinary Bcl-2 levels are reliably elevated during early and late stages of ovarian cancer. Our biosensor uses shear horizontal (SH) surface acoustic waves (SAWs) on surface functionalized ST-cut Quartz to quantify the mass loading change by protein adhesion to the delay path. SH-SAWs were generated and received by a pair of micro-fabricated interdigital transducers (IDTs) separated by a judiciously designed delay path. The delay path was surface-functionalized with monoclonal antibodies, ODMS, Protein A/G and Pluronic F127 for optimal Bcl-2 capture with minimal non-specific adsorption. Bcl-2 concentrations were quantified by the resulting resonance frequency shift detected by a custom designed resonator circuit. The target sensitivity for diagnosis and identifying the stage of ovarian cancer was successfully achieved with demonstrated Bcl-2 detection capability of 500 pg/mL. It was also shown that resonance frequency shift increases linearly with increasing Bcl-2 concentration.